Overview

The development of new pharmaceuticals and biopharmaceuticals is a long and costly journey. The R&D and resulting manufacturing pathways for active pharmaceutical ingredients and drug products are often fragmented and influenced by human expertise and bias. Most importantly, this manufacturing sector is solvent-intensive and has large carbon footprints and waste-to-product ratios.

This talk will showcase the role of digital transformation in the development of greener-by-design and precision medicines. It will highlight how the synergetic combinations of artificial intelligence, digital technologies, and life cycle assessment, across all development stages, can help reconcile sustainability with drug safety and efficacy.

Speaker

Brahim Benyahia, Professor of Chemical Engineering, Loughborough University

Brahim is a professor of chemical engineering and pharmaceutical manufacturing at Loughborough University. With 15 years of research experience, he has played an active role in several major milestones in pharmaceutical manufacturing. He has also witnessed and contributed to transformative changes that have led to the increased adoption of more effective manufacturing technologies, digital tools, and robust quality management systems. Brahim is a leading member of several national and international research consortia, including Horizon PharmEco, SusPharma, REFINE, and the EPSRC Manufacturing Made Smarter DM2.

His current research focuses on digitally enabled sustainable pharmaceutical manufacturing, green-by-design recipes and processes, artificial intelligence, systems approaches, self-driven laboratories, digital quality control, and quality by digital design.

The material presented has not been peer-reviewed. Any opinions are the presenter’s own and do not necessarily represent those of IChemE or the Biochemical Engineering Special Interest Group. The information is given in good faith but without any liability on the part of IChemE.